Buy Or Sell Opportunity • Aug 07
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 7.6% to RM0.73. The fair value is estimated to be RM0.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 48%. Reported Earnings • May 23
Third quarter 2026 earnings released: EPS: RM0.007 (vs RM0.02 in 3Q 2025) Third quarter 2026 results: EPS: RM0.007 (down from RM0.02 in 3Q 2025). Revenue: RM11.9m (down 10% from 3Q 2025). Net income: RM531.0k (down 66% from 3Q 2025). Profit margin: 4.5% (down from 12% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 28
Second quarter 2026 earnings released: EPS: RM0.007 (vs RM0.004 in 2Q 2025) Second quarter 2026 results: EPS: RM0.007 (up from RM0.004 in 2Q 2025). Revenue: RM13.2m (up 17% from 2Q 2025). Net income: RM595.0k (up 113% from 2Q 2025). Profit margin: 4.5% (up from 2.5% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings. New Risk • Nov 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 12% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (RM64.4m market cap, or US$15.6m). Reported Earnings • Oct 23
Full year 2025 earnings released: EPS: RM0.079 (vs RM0.064 in FY 2024) Full year 2025 results: EPS: RM0.079 (up from RM0.064 in FY 2024). Revenue: RM53.0m (up 3.1% from FY 2024). Net income: RM6.35m (up 24% from FY 2024). Profit margin: 12% (up from 9.9% in FY 2024). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings. Announcement • Oct 18
Imaspro Corporation Berhad, Annual General Meeting, Nov 19, 2025 Imaspro Corporation Berhad, Annual General Meeting, Nov 19, 2025, at 10:00 Singapore Standard Time. Location: kelab golf sultan abdul aziz shah, no. 1, rumah kelab golf 13/6, 40100 shah alam, selangor darul ehsan, Malaysia Announcement • Sep 21
Imaspro Corporation Berhad Appoints Chan Kim Hing as Member of the Remuneration Committee, Effective September 19, 2025 Imaspro Corporation Berhad appointed Mr. Chan Kim Hing as a Member of the Remuneration Committee, effective September 19, 2025. Age is 58. Directorate: Independent and Non-Executive. The composition of the Remuneration Committee after the change includes Kevin Chung Li Kien as Chairman, Independent Non-Executive Director, and Chan Kim Hing and Ooi Ming Chu as Members, both serving as Independent Non-Executive Directors. New Risk • Jun 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (RM70.4m market cap, or US$16.6m). Buy Or Sell Opportunity • Jun 05
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 1.7% to RM0.88. The fair value is estimated to be RM0.72, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 52%. Reported Earnings • May 21
Third quarter 2025 earnings released: EPS: RM0.02 (vs RM0.016 in 3Q 2024) Third quarter 2025 results: EPS: RM0.02 (up from RM0.016 in 3Q 2024). Revenue: RM13.2m (up 3.0% from 3Q 2024). Net income: RM1.56m (up 24% from 3Q 2024). Profit margin: 12% (up from 9.8% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 39% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 19
Second quarter 2025 earnings released: EPS: RM0.004 (vs RM0.007 in 2Q 2024) Second quarter 2025 results: EPS: RM0.004 (down from RM0.007 in 2Q 2024). Revenue: RM11.3m (down 7.7% from 2Q 2024). Net income: RM280.0k (down 47% from 2Q 2024). Profit margin: 2.5% (down from 4.3% in 2Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. New Risk • Nov 21
New major risk - Revenue and earnings growth Earnings have declined by 4.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (RM81.6m market cap, or US$18.3m). Reported Earnings • Oct 25
Full year 2024 earnings released: EPS: RM0.064 (vs RM0.022 in FY 2023) Full year 2024 results: EPS: RM0.064 (up from RM0.022 in FY 2023). Revenue: RM51.5m (up 2.6% from FY 2023). Net income: RM5.12m (up 185% from FY 2023). Profit margin: 9.9% (up from 3.6% in FY 2023). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings. Announcement • Oct 21
Imaspro Corporation Berhad, Annual General Meeting, Nov 20, 2024 Imaspro Corporation Berhad, Annual General Meeting, Nov 20, 2024, at 10:00 Singapore Standard Time. Location: tricor boardroom, unit 30-01, level 30, tower a, vertical business suite, avenue 3, bangsar south, no. 8, jalan kerinchi, 59200 kuala lumpur, Malaysia Reported Earnings • Aug 31
Full year 2024 earnings released: EPS: RM0.064 (vs RM0.019 in FY 2023) Full year 2024 results: EPS: RM0.064 (up from RM0.019 in FY 2023). Revenue: RM51.5m (up 2.6% from FY 2023). Net income: RM5.12m (up 229% from FY 2023). Profit margin: 9.9% (up from 3.1% in FY 2023). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Reported Earnings • May 17
Third quarter 2024 earnings released: EPS: RM0.016 (vs RM0.002 loss in 3Q 2023) Third quarter 2024 results: EPS: RM0.016 (up from RM0.002 loss in 3Q 2023). Revenue: RM12.8m (down 20% from 3Q 2023). Net income: RM1.26m (up RM1.43m from 3Q 2023). Profit margin: 9.8% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 22
Second quarter 2024 earnings released: EPS: RM0.007 (vs RM0.006 loss in 2Q 2023) Second quarter 2024 results: EPS: RM0.007 (up from RM0.006 loss in 2Q 2023). Revenue: RM12.2m (up 25% from 2Q 2023). Net income: RM524.0k (up RM991.0k from 2Q 2023). Profit margin: 4.3% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment deteriorates as stock falls 44% After last week's 44% share price decline to RM1.99, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 23x in the Chemicals industry in Malaysia. Negligible returns to shareholders over past three years. Upcoming Dividend • Dec 26
Upcoming dividend of RM0.035 per share at 0.8% yield Eligible shareholders must have bought the stock before 02 January 2024. Payment date: 16 January 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.8%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (2.9%). Buying Opportunity • Dec 12
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 23%. The fair value is estimated to be RM5.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 19%. Reported Earnings • Oct 27
Full year 2023 earnings released: EPS: RM0.019 (vs RM0.16 in FY 2022) Full year 2023 results: EPS: RM0.019 (down from RM0.16 in FY 2022). Revenue: RM50.1m (down 35% from FY 2022). Net income: RM1.55m (down 88% from FY 2022). Profit margin: 3.1% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings. Announcement • Oct 24
Imaspro Corporation Berhad, Annual General Meeting, Nov 22, 2023 Imaspro Corporation Berhad, Annual General Meeting, Nov 22, 2023, at 10:00 Singapore Standard Time. Location: Tricor Boardroom, Unit 30-01, Level 30, Tower A, Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi, 59200 Kuala Lumpur Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 30 June 2023 together with the Reports of the Directors and Auditors thereon; to approve the payment of a first and final single tier dividend of 3.5 sen per share, in respect of the financial year ended 30 June 2023; to approve the payment of Directors' Fees of up to RM175,500 and Benefits of up to RM15,000 for the period commencing on the date immediately after this 19th Annual General Meeting until the next Annual General Meeting of the Company; to re-elect Tong Chin Hen, who retires pursuant to Clause 76(3) of the Company's Constitution, as Director of the Company; to re-elect Ooi Ming Chu, who retires pursuant to Clause 78 of the Company's Constitution, as Director of the Company; and to discuss other matters. Announcement • Aug 24
Imaspro Corporation Berhad Proposes First and Final Single-Tier Dividend for the Financial Year Ended 30 June 2023 Imaspro Corporation Berhad proposed first and final single-tier dividend of 3.5 sen per ordinary share in respect of the financial year ended 30 June 2023, subject to the shareholders’ approval at the forthcoming Annual General Meeting. Reported Earnings • Aug 24
Full year 2023 earnings released: EPS: RM0.019 (vs RM0.16 in FY 2022) Full year 2023 results: EPS: RM0.019 (down from RM0.16 in FY 2022). Revenue: RM50.1m (down 35% from FY 2022). Net income: RM1.55m (down 88% from FY 2022). Profit margin: 3.1% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings. Reported Earnings • May 19
Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.021 profit in 3Q 2022) Third quarter 2023 results: RM0.002 loss per share (down from RM0.021 profit in 3Q 2022). Revenue: RM16.1m (down 3.6% from 3Q 2022). Net loss: RM168.0k (down 110% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 18
Imaspro Corporation Berhad Announces Appointment of Ooi Ming Chu as Independent and Non Executive Director Imaspro Corporation Berhad announced appointment of Miss Ooi Ming Chu as Independent and Non Executive Director. Age 47, Date of change 17 May 2023. Qualifications: Professional Qualification, Accountancy- Malaysian Institute of Accountants Chartered Accountant, Professional Qualification, Accountancy, Malaysian Institute of Certified Public Accountants- Provisional Member and Degree- Accountancy- Universiti Putra Malaysia (UPM). Working experience: Ms Ooi Ming Chu ("Ms Ooi") has more than 20 years of experience in providing audit, accounting and business advisory services to private companies and multinationals in Malaysia. Ms Ooi is also involved in preparing group accounts, accountants' report for listing exercises, financial due diligence and share valuation of companies. Ms Ooi currently is the Managing Partner of MyKira Solutions Sdn Bhd. Reported Earnings • Feb 24
Second quarter 2023 earnings released: RM0.006 loss per share (vs RM0.069 profit in 2Q 2022) Second quarter 2023 results: RM0.006 loss per share (down from RM0.069 profit in 2Q 2022). Revenue: RM9.77m (down 68% from 2Q 2022). Net loss: RM467.0k (down 109% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 38% per year. Upcoming Dividend • Dec 23
Upcoming dividend of RM0.035 per share Eligible shareholders must have bought the stock before 30 December 2022. Payment date: 16 January 2023. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 0.6%. Lower than top quartile of Malaysian dividend payers (5.0%). Lower than average of industry peers (5.7%). Reported Earnings • Nov 19
First quarter 2023 earnings released: EPS: RM0.019 (vs RM0.072 in 1Q 2022) First quarter 2023 results: EPS: RM0.019 (down from RM0.072 in 1Q 2022). Revenue: RM12.8m (down 3.5% from 1Q 2022). Net income: RM1.49m (down 74% from 1Q 2022). Profit margin: 12% (down from 43% in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Kim Chan was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment improved over the past week After last week's 16% share price gain to RM6.30, the stock trades at a trailing P/E ratio of 40.3x. Average trailing P/E is 12x in the Chemicals industry in Malaysia. Total returns to shareholders of 205% over the past three years. Reported Earnings • Oct 21
Full year 2022 earnings released: EPS: RM0.16 (vs RM0.076 in FY 2021) Full year 2022 results: EPS: RM0.16 (up from RM0.076 in FY 2021). Revenue: RM76.6m (up 34% from FY 2021). Net income: RM12.5m (up 106% from FY 2021). Profit margin: 16% (up from 11% in FY 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Announcement • Oct 19
Imaspro Corporation Berhad, Annual General Meeting, Nov 16, 2022 Imaspro Corporation Berhad, Annual General Meeting, Nov 16, 2022, at 10:00 Singapore Standard Time. Location: Tricor Business Centre, Manuka 2 & 3 Meeting Room, Unit 29-01, Level 29, Tower A, Jalan Kerinchi, 59200 Kuala Lumpur Kuala Lumpur Malaysia Announcement • Oct 18
Imaspro Corporation Berhad Announces First and Final Dividend for the Financial Year Ended 30 June 2022, Payable on January 16, 2023 Imaspro Corporation Berhad announced the first and final single-tier dividend of 3.5 sen per share for the financial year ended 30 June 2022, Ex-Date is on December 30, 2022 Entitlement date is on 03 January 2023, and Payment Date is on 16 January 2023. Announcement • Aug 25
Imaspro Corporation Berhad Proposes First and Final Single-Tier Dividend for the Financial Year Ended 30 June 2022 Imaspro Corporation Berhad announced that the company is proposing a first and final single-tier dividend of 3.5 sen per ordinary share in respect of the financial year ended 30 June 2022, subject to the shareholders’ approval at the forthcoming Annual General Meeting. Reported Earnings • Aug 25
Full year 2022 earnings released: EPS: RM0.16 (vs RM0.076 in FY 2021) Full year 2022 results: EPS: RM0.16 (up from RM0.076 in FY 2021). Revenue: RM76.6m (up 34% from FY 2021). Net income: RM12.5m (up 106% from FY 2021). Profit margin: 16% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 19
Third quarter 2022 earnings released: EPS: RM0.021 (vs RM0.016 in 3Q 2021) Third quarter 2022 results: EPS: RM0.021 (up from RM0.016 in 3Q 2021). Revenue: RM16.7m (up 3.7% from 3Q 2021). Net income: RM1.65m (up 25% from 3Q 2021). Profit margin: 9.9% (up from 8.2% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Kim Chan was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improved over the past week After last week's 19% share price gain to RM2.95, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 56% over the past three years. Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment deteriorated over the past week After last week's 16% share price decline to RM2.20, the stock trades at a trailing P/E ratio of 16.5x. Average trailing P/E is 15x in the Chemicals industry in Malaysia. Total returns to shareholders of 3.1% over the past three years. Upcoming Dividend • Dec 28
Upcoming dividend of RM0.035 per share Eligible shareholders must have bought the stock before 04 January 2022. Payment date: 20 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of Malaysian dividend payers (4.5%). Lower than average of industry peers (3.3%). Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment improved over the past week After last week's 18% share price gain to RM2.70, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 15x in the Chemicals industry in Malaysia. Total returns to shareholders of 32% over the past three years. Reported Earnings • Nov 18
First quarter 2022 earnings released: EPS RM0.072 (vs RM0.014 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: RM13.2m (up 14% from 1Q 2021). Net income: RM5.72m (up 399% from 1Q 2021). Profit margin: 43% (up from 9.9% in 1Q 2021). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 20
Full year 2021 earnings released: EPS RM0.076 (vs RM0.039 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: RM57.0m (down 14% from FY 2020). Net income: RM6.08m (up 95% from FY 2020). Profit margin: 11% (up from 4.7% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Reported Earnings • Aug 26
Full year 2021 earnings released: EPS RM0.076 (vs RM0.039 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: RM57.0m (down 14% from FY 2020). Net income: RM6.08m (up 95% from FY 2020). Profit margin: 11% (up from 4.7% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • May 20
Third quarter 2021 earnings released: EPS RM0.017 (vs RM0.011 in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: RM16.1m (flat on 3Q 2020). Net income: RM1.32m (up 46% from 3Q 2020). Profit margin: 8.2% (up from 5.6% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorated over the past week After last week's 18% share price decline to RM2.05, the stock trades at a trailing P/E ratio of 37.1x. Average trailing P/E is 22x in the Chemicals industry in Malaysia. Total returns to shareholders of 17% over the past three years. Is New 90 Day High Low • Mar 10
New 90-day high: RM2.30 The company is up 15% from its price of RM2.00 on 10 December 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. Reported Earnings • Feb 06
Second quarter 2021 earnings released: EPS RM0.025 (vs RM0.008 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM16.0m (down 10% from 2Q 2020). Net income: RM1.96m (up 190% from 2Q 2020). Profit margin: 12% (up from 3.8% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Jan 29
New 90-day low: RM1.90 The company is down 13% from its price of RM2.18 on 30 October 2020. The Malaysian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: RM1.99 The company is down 4.0% from its price of RM2.07 on 17 September 2020. The Malaysian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 35% over the same period. Is New 90 Day High Low • Nov 17
New 90-day low: RM2.04 The company is down 6.0% from its price of RM2.17 on 19 August 2020. The Malaysian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. Reported Earnings • Oct 22
Full year earnings released - EPS RM0.039 Over the last 12 months the company has reported total profits of RM3.12m, largely unchanged from the prior year. Total revenue was RM66.5m over the last 12 months, up 3.6% from the prior year. Profit margins were 4.7%, which is in line with last year. Is New 90 Day High Low • Oct 01
New 90-day high: RM2.31 The company is up 10.0% from its price of RM2.10 on 03 July 2020. The Malaysian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 7.0% over the same period. 
